Abbott Faces $70M Suit Over Discontinued Stent
Abbott Laboratories has been stung with a $70 million lawsuit for allegedly cheating a Cayman Islands-based investor out of royalties when the pharmaceutical company stopped developing the ZoMaxx stent....To view the full article, register now.
Already a subscriber? Click here to view full article